Hostname: page-component-848d4c4894-pjpqr Total loading time: 0 Render date: 2024-06-17T09:17:24.698Z Has data issue: false hasContentIssue false

P03-154 - Serum Levels of S100B Proteins as a Marker of Positive Psychopathology in Schizophrenic Inpatients

Published online by Cambridge University Press:  17 April 2020

A.L. Morera-Fumero
Affiliation:
Departamento de Medicina Interna, Dermatologia y Psiquiatria, Universidad de La Laguna, Santa Cruz de Tenerife, Spain
E. Diaz-Mesa
Affiliation:
Servicio de Psiquiatria, Hospital Universitario de Canarias, La Laguna, Spain
P. Abreu-Gonzalez
Affiliation:
Fisiologia, Universidad de La Laguna, Santa Cruz de Tenerife, Spain
M. Henry
Affiliation:
Servicio de Psiquiatria, Hospital Universitario de Canarias, La Laguna, Spain
A. Jimenez-Sosa
Affiliation:
Unidad Mixta de Investigacion, Hospital Universitario de Canarias, La Laguna, Spain
J. Garcia-Valdecasas-Campelo
Affiliation:
Servicio de Psiquiatria, Hospital Universitario de Canarias, La Laguna, Spain
A. Intxausti
Affiliation:
Servicio de Psiquiatria, Hospital Universitario de Canarias, La Laguna, Spain
L. Fernandez-Lopez
Affiliation:
Servicio de Psiquiatria, Hospital Universitario de Canarias, La Laguna, Spain
S. Yelmo
Affiliation:
Servicio de Psiquiatria, Hospital Universitario de Canarias, La Laguna, Spain
R. Gracia-Marco
Affiliation:
Servicio de Psiquiatria, Hospital Universitario de Canarias, La Laguna, Spain

Abstract

Introduction

Schizophrenia is a chronic disease. Several etiopathogenic aetiologies have been posed, among them the existence of cerebral inflammation. S100B is a calcium-binding protein, mainly produced and secreted by astrocytes, that mediates the interaction among glial cells and between glial cells and neurons. Serum S100B levels have been proposed as a peripheral marker of brain inflammation.

Objectives

The aim of this research is to study if the serum level of the protein S100B has relationship with positive psychopathology.

Methods

31 paranoid schizophrenic inpatients (22 male and 9 female, 36.7±10.3 years) meeting DSM-IV criteria participated in the study. Blood was sampled by venipuncture at 12:00 and 24:00 hours. Blood extractions were carried out during the first 48 hours after hospital admission. Psychopathology was assessed by the Positive and Negative Syndrome Scale (PANSS). Serum S100B levels were measured by sandwich ELISA techniques.

Results

Correlations between serum levels of S100B protein and PANSS positive scores are shown in the following table. The first figure corresponds to the Pearson's correlation coefficient, while the figure in brackets corresponds to its statistical significance.

S100BTotal Positive ScoreDelusionsConceptual disorganizationHallucinationsHyperactivityGrandiositySuspiciousness/ persecutionHostility
12:000.354 (0.051)0.210 (0.249)0.291 (0.106)0.412 (0.019)-0.128 (0.486)0.274 (0.135)0.010 (0.957)0.026 (0.887)
24:000.462 (0.009)0.266 (0.141)0.446 (0.011)0.345 (0.053)-0.148 (0.419)0.486 (0.006)0.064 (0.728)0.013 (0.942)

[panss]

Conclusions

Serum levels of S100B protein may be used as a biological marker of positive psychopathology in paranoid schizophrenia.Acknowledgement

Type
Psychotic disorders / Schizophrenia
Copyright
Copyright © European Psychiatric Association 2010

This study was partly supported by a grant (PI: 08/115) of the Fundacion Canaria de Investigacion y Salud (FUNCIS).

Submit a response

Comments

No Comments have been published for this article.